Menu
Back to Journals » Cancer Management and Research » Volume 2 » default
Cancer Management and Research
ISSN: 1179-1322
- View all (4487)
- Volume 15, 2023 (46)
- Volume 14, 2022 (330)
- Volume 13, 2021 (890)
- Volume 12, 2020 (1256)
- Volume 11, 2019 (969)
- Volume 10, 2018 (645)
- Volume 9, 2017 (89)
- Volume 8, 2016 (17)
- Volume 7, 2015 (33)
- Volume 6, 2014 (43)
- Volume 5, 2013 (41)
- Volume 4, 2012 (47)
- Volume 3, 2011 (32)
- Volume 2, 2010 (32)
- Volume 1, 2009 (17)
Archive: Volume 2, 2010
Efficacy and safety of fentanyl buccal for cancer pain management by administration through a soluble film: an update
Marvin Omar Delgado-Guay
Cancer Management and Research 2010, 2:303-306
Published Date: 24 November 2010
Cancer chemotherapy: targeting folic acid synthesis
Nicole Hagner, Markus Joerger
Cancer Management and Research 2010, 2:293-301
Published Date: 19 November 2010
The disparity of health facilities in an urban area discourages proposed treatment application in inoperable lung cancer patients
Georgios Hillas, Petros Bakakos, Miltiadis Trichas, et al
Cancer Management and Research 2010, 2:287-291
Published Date: 15 November 2010
Review of catumaxomab in the treatment of malignant ascites
Martin Sebastian
Cancer Management and Research 2010, 2:283-286
Published Date: 8 November 2010
The potential carcinogenic risk of tanning beds: clinical guidelines and patient safety advice
Mette Mogensen, Gregor BE Jemec
Cancer Management and Research 2010, 2:277-282
Published Date: 28 October 2010
FACE: the barefaced facts of AI potency
Alain Monnier
Cancer Management and Research 2010, 2:267-276
Published Date: 27 October 2010
Epigenomics in cancer management
Fabricio F Costa
Cancer Management and Research 2010, 2:255-265
Published Date: 27 October 2010
Radiotherapy combined with hormonal therapy in prostate cancer: the state of the art
Piotr Milecki, Piotr Martenka, Andrzej Antczak, et al
Cancer Management and Research 2010, 2:243-253
Published Date: 11 October 2010
New developments in treatment of ovarian carcinoma: focus on trabectedin
Philippe A Cassier, Aude Duret, Olivier Trédan, et al
Cancer Management and Research 2010, 2:233-242
Published Date: 1 October 2010
Role of intranasal fentanyl in breakthrough pain management in cancer patients
Wojciech Leppert
Cancer Management and Research 2010, 2:225-232
Published Date: 30 September 2010
Frequency of heterozygous TET2 deletions in myeloproliferative neoplasms
Joseph Tripodi, Ronald Hoffman, Vesna Najfeld, et al
Cancer Management and Research 2010, 2:219-223
Published Date: 17 September 2010
Positive response to neoadjuvant cyclophosphamide and doxorubicin in topoisomerase II nonamplified/HER2/neu negative/polysomy 17 absent breast cancer patients
Henry G Kaplan, Judith A Malmgren, Mary Atwood, et al
Cancer Management and Research 2010, 2:213-218
Published Date: 20 August 2010
Treatment of cutaneous melanoma: current approaches and future prospects
Alain P Algazi, Christopher W Soon, Adil I Daud
Cancer Management and Research 2010, 2:197-211
Published Date: 17 August 2010
Efficacy and safety of amrubicin hydrochloride for treatment of relapsed small cell lung cancer
Daiki Ogawara, Minoru Fukuda, Yoichi Nakamura, et al
Cancer Management and Research 2010, 2:191-195
Published Date: 11 August 2010
Temsirolimus in the treatment of relapsed and/or refractory mantle cell lymphoma
S Galimberti, M Petrini
Cancer Management and Research 2010, 2:181-189
Published Date: 28 June 2010
Ixabepilone development across the breast cancer continuum: a paradigm shift
Nuhad K Ibrahim
Cancer Management and Research 2010, 2:169-179
Published Date: 30 June 2010
Cetuximab in the treatment of head and neck cancer: preliminary results outside clinical trials
Didier Dequanter, Mohammad Shahla, Pascal Paulus, et al
Cancer Management and Research 2010, 2:165-168
Published Date: 28 June 2010
Cancer prevention, aerobic capacity, and physical functioning in survivors related to physical activity: a recent review
Matthew S Wiggins, Emily M Simonavice
Cancer Management and Research 2010, 2:157-164
Published Date: 9 June 2010
Role of erlotinib in first-line and maintenance treatment of advanced non-small-cell lung cancer
Noemí Reguart, Andrés Felipe Cardona, Rafael Rosell
Cancer Management and Research 2010, 2:143-156
Published Date: 1 June 2010
A pilot study assessing social support among cancer patients enrolled on clinical trials: a comparison of younger versus older adults
Paul J Novotny, Denise J Smith, Lorna Guse, et al
Cancer Management and Research 2010, 2:133-142
Published Date: 27 May 2010
Management of metastatic renal cell carcinoma in patients with poor prognosis
Andrea Bullock, David F McDermott, Michael B Atkins
Cancer Management and Research 2010, 2:123-132
Published Date: 24 May 2010
Identification of a novel prostate cancer biomarker, caveolin-1: Implications and potential clinical benefit
Paul G Corn, Timothy C Thompson
Cancer Management and Research 2010, 2:111-122
Published Date: 10 May 2010
Global cancer research initiative
Richard R Love
Cancer Management and Research 2010, 2:105-109
Published Date: 3 May 2010
Role of bevacizumab therapy in the management of glioblastoma
Scott J Peak, Victor A Levin
Cancer Management and Research 2010, 2:97-104
Published Date: 22 April 2010
Metastatic clear cell carcinoma of the kidney: therapeutic role of bevacizumab
Ronald M Bukowski
Cancer Management and Research 2010, 2:83-96
Published Date: 26 March 2010
Rituximab for the treatment of patients with chronic lymphocytic leukemia
M Gentile, E Vigna, C Mazzone, et al
Cancer Management and Research 2010, 2:71-81
Published Date: 11 March 2010
Everolimus – a new approach in the treatment of renal cell carcinoma
G Anandappa, AE Hollingdale, TG Eisen
Cancer Management and Research 2010, 2:61-70
Published Date: 9 March 2010
Role of denileukin diftitox in the treatment of persistent or recurrent cutaneous T-cell lymphoma
Frederick Lansigan, Diane M Stearns, Francine Foss
Cancer Management and Research 2010, 2:53-59
Published Date: 5 February 2010
Evaluation of degarelix in the management of prostate cancer
Hendrik Van Poppel
Cancer Management and Research 2010, 2:39-52
Published Date: 25 January 2010
Optimal management of cancer anorexia–cachexia syndrome
Josep M Argilés, Mireia Olivan, Sílvia Busquets, et al
Cancer Management and Research 2010, 2:27-38
Published Date: 22 January 2010
Role of lapatinib in the first-line treatment of patients with metastatic breast cancer
Catherine Oakman, Marta Pestrin, Elena Zafarana, et al
Cancer Management and Research 2010, 2:13-25
Published Date: 7 January 2010
Use of granisetron transdermal system in the prevention of chemotherapy-induced nausea and vomiting: a review
Albert Tuca
Cancer Management and Research 2010, 2:1-12
Published Date: 16 December 2009